Aclarion's Nociscan Hits Milestone at The London Clinic
Event summary
- Aclarion released a video featuring John Sutcliffe, Lead Clinician at The London Spine Clinic, showcasing Nociscan's use in chronic low back pain evaluation.
- Nearly 100 Nociscan procedures performed at The London Clinic, indicating growing adoption.
- Nociscan leverages MR spectroscopy and AI algorithms to identify painful discs in the lumbar spine.
- Sutcliffe highlights Nociscan's ability to complement traditional imaging with objective data.
The big picture
Aclarion's Nociscan is gaining traction in the chronic low back pain market, a significant global healthcare challenge affecting 266 million people. The technology's ability to provide objective data complements traditional imaging, potentially improving diagnostic accuracy and treatment outcomes. This milestone at The London Clinic underscores the growing acceptance of AI-driven diagnostic tools in clinical practice.
What we're watching
- Adoption Pace
- Whether Aclarion can sustain the current adoption rate of Nociscan in other leading medical centers.
- Clinical Integration
- How deeply Nociscan becomes integrated into routine clinical practice for chronic low back pain evaluation.
- Market Expansion
- The pace at which Aclarion can expand Nociscan's use beyond The London Clinic to other international markets.